FOAMEd Wiki - Ischemic Stroke, last updated 4/16/25
Workup and Guidelines
Workup | Source | Year |
IBCC | 2022 | |
EMCrit | 2022 | |
EMCrit | 2022 | |
RebelEM | 2018 |
Posterior CVA | Source | Year |
emDocs | 2017 | |
emDocs | 2020 | |
CoreEM | 2019 |
Protocols, Workflows, and Guidelines | Source | Year |
AHA / ASA | 2018 | |
AHA / ASA | 2021 | |
JournalFeed $ | 2020 | |
SGEM | 2021 | |
SGEM | 2020 |
Thrombolytic & Antiplatelet Therapy
Thrombolytic Positive Trials | Source | Year |
WikiJournalClub | 2015 | |
WikiJournalClub | 2017 | |
TheNNT | 2019 |
Lytic Debate | Source | Year |
The NNT | 2013 | |
SGEM | 2014 | |
First10EM | 2017 | |
SGEM | 2019 | |
REBEL EM | 2020 | |
SGEM | 2020 | |
ACEP | 2020 | |
The NNT | 2021 | |
First10EM | 2021 |
Lytic Contraindications | Source | Year |
MDCalc | ||
ALiEM | 2022 |
Timing | Source | Year |
JournalFeed $ | 2018 | |
JournalFeed $ | 2018 | |
REBEL EM | 2019 | |
JournalFeed $ | 2019 | |
EMCrit | 2019 | |
REBEL EM | 2020 | |
REBEL EM | 2021 | |
SGEM | 2021 |
Dosing | Source | Year |
MDCalc | ||
MDCalc | ||
REBEL EM | 2020 |
Alteplase (TPA) vs. Tenecteplase | Source | Year |
Core EM | 2018 | |
REBEL EM | 2022 | |
SGEM | 2022 |
Antiplatelet Therapy | Source | Year |
REBEL EM | 2018 | |
JournalFeed $ | 2018 | |
SGEM | 2020 | |
REBEL EM | 2020 | |
REBEL EM | 2023 |
LVO & Neuroendovascular Therapy
General Evidence & Protocols | Source | Year |
emDocs | 2022 | |
REBEL EM | 2018 | |
EM Cases | 2019 | |
First10EM | 2017 | |
JournalFeed $ | 2019 |
Time Window | Source | Year |
emDocs | 2023 | |
The Bottom Line | 2018 |
EVT vs. EVT + tPA – Comparative Trials | Source | Year |
REBEL EM | 2020 | |
REBEL EM | 2021 | |
SGEM | 2021 | |
REBEL EM | 2021 | |
REBEL EM | 2022 |